Tumor necrosis factor-alpha and myocardial function in patients with myotonic dystrophy type 1.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Neurological Sciences

• Publication date

  2002-09-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0022-510X(02)00193-4PMID 12163195
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proinflammatory Cytokines in Heart Disease

  2001cited by this paper
• Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy?

  2001cited by this paper
• Abnormal cytokine and adrenocortical hormone regulation in myotonic dystrophy.

  2000cited by this paper
• New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1)

  2000cited by this paper
• Cytokines as emerging targets in the treatment of heart failure.

  2000cited by this paper
• Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy.

  2000cited by this paper
• Haemostatic Abnormalities, Cardiac Involvement and Serum Tumor Necrosis Factor Levels in X-linked Dystrophic Patients

  1999cited by this paper
• A 10-year study of mortality in a cohort of patients with myotonic dystrophy

  1999cited by this paper
• Tumor necrosis factor system activity is associated with insulin resistance and dyslipidemia in myotonic dystrophy.

  1999cited by this paper
• Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications.

  1998cited by this paper
• Dispersion of QT Interval in Premature Ventricular Beats as a Marker of Susceptibility to Arrhythmic Events

  1998cited by this paper
• Cardiac disease in myotonic dystrophy.

  1997cited by this paper
• Doppler echocardiographic assessment of left ventricular diastolic function in myotonic dystrophy.

  1997cited by this paper
• Myocardial myotonia in myotonic muscular dystrophy.

  1995cited by this paper
• Signal-averaged electrocardiography in myotonic dystrophy.

  1995cited by this paper
• Correlation between cardiac involvement and CTG trinucleotide repeat length in myotonic dystrophy.

  1995cited by this paper
• QT dispersion.

  1994cited by this paper
• An unstable triplet repeat in a gene related to myotonic muscular dystrophy.

  1992cited by this paper
• Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

  1992cited by this paper
• Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene.

  1992cited by this paper
• Ventricular late potentials in myotonic dystrophy.

  1991cited by this paper
• Standards for analysis of ventricular late potentials using high resolution or signal-averaged electrocardiography. A statement by a Task Force Committee between the European Society of Cardiology, the American Heart Association and the American College of Cardiology.

  1991cited by this paper
• Standards for analysis of ventricular late potentials using high-resolution or signal-averaged electrocardiography. A statement by a Task Force Committee of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology.

  1991cited by this paper
• Metabolic effects of cachectin/tumor necrosis factor are modified by site of production. Cachectin/tumor necrosis factor-secreting tumor in skeletal muscle induces chronic cachexia, while implantation in brain induces predominantly acute anorexia.

  1990cited by this paper
• Ventricular tachycardia and sudden death in myotonic dystrophy.

  1988cited by this paper
• Increased platelet aggregation and release reaction in myotonic dystrophy.

  1988cited by this paper
• The natural history of cardiac involvement in myotonic dystrophy: An eight‐year follow‐up in 17 patients

  1988cited by this paper
• Pathology of the cardiac conduction system in myotonic dystrophy: a study of 12 cases.

  1988cited by this paper
• Platelet aggregation in myotonia.

  1985cited by this paper
• Cardiac involvement in myotonic muscular dystrophy (Steinert's disease): a prospective study of 25 patients.

  1984cited by this paper
• Relation between late potentials on the body surface and directly recorded fragmented electrograms in patients with ventricular tachycardia.

  1983cited by this paper
• Use of Signals in the Terminal QRS Complex to Identify Patients with Ventricular Tachycardia After Myocardial Infarction

  1981cited by this paper
• Cardiac abnormalities in myotonic dystrophy. Electrophysiologic and histopathologic studies.

  1979cited by this paper
• Myotonia dystrophica with heart involvement: an electron microscopic study of skeletal, cardiac, and smooth muscle.

  1978cited by this paper
• Echocardiographic Evaluation of Posterior Left Ventricular Wall Motion in Muscular Dystrophy

  1975cited by this paper
• Cardiomyopathy in myotonic dystrophy. A light and electron microscopic study of the myocardium.

  1973cited by this paper
• Myotonic dystrophy.

  1971cited by this paper

• Neural Damage and Inflammation in Myotonic Dystrophy Type 1: Longitudinal Analysis of Serum NFL, GFAP, and IL-6.

  2025cites this paper
• The Bi-directional Relationship Between Sleep and Inflammation in Muscular Dystrophies: A Narrative Review.

  2023cites this paper
• Transcriptome Analysis Reveals Altered Inflammatory Pathway in an Inducible Glial Cell Model of Myotonic Dystrophy Type 1

  2021cites this paper
• The sustained expression of Cas9 targeting toxic RNAs reverses disease phenotypes in mouse models of myotonic dystrophy type 1

  2020cites this paper
• miR-7 Restores Phenotypes in Myotonic Dystrophy Muscle Cells by Repressing Hyperactivated Autophagy

  2019cites this paper
• Adaptations du muscle squelettique induites par l'entraînement physique en résistance, aigu et chronique, chez les patients atteints de dystrophie myotonique de type 1

  2017cites this paper
• Safety of ustekinumab for the treatment of psoriasis vulgaris with myotonic dystrophy

  2016cites this paper
• Myotonic dystrophy and the heart: A systematic review of evaluation and management.

  2015cites this paper
• The Role of the Immune System in Triplet Repeat Expansion Diseases

  2015cites this paper
• Myotonic Dystrophy Type 1: Focus on the RNA Pathology and Therapy

  2012cites this paper
• Repeat expansion diseases: when a good RNA turns bad

  2010cites this paper
• Myotonic Dystrophies 1 and 2: Complex Diseases with Complex Mechanisms

  2010cites this paper
• [Chronic respiratory failure and Steinert's myotonia].

  2009cites this paper
• [Chronic respiratory failure and Steinert's myotonia].

  2009cites this paper
• The RNA-binding Protein CUGBP1 Regulates Stability of Tumor Necrosis Factor mRNA in Muscle Cells

  2008cites this paper
• Fascioscapulohumeral muscular dystrophy: a progressive degenerative disease that responds to diltiazem.

  2005cites this paper
• Postabsorptive and insulin-stimulated energy and protein metabolism in patients with myotonic dystrophy type 1.

  2004influential citation